In this investigation, we discovered that high expression of KIAA1522 in HCC patients was consistent with the level of conventional diagnostic marker and was linked with numerous advanced cancer clinical aspects (such as pathological stage, T stage histological grade, and poor OS). This evidence concerns the gene NHSL3 and hepatocellular carcinoma.